作者: James T. Koerber , Melissa A. Kotterman , Bum-Yeol Hwang , David V. Schaffer
DOI:
关键词:
摘要: The present disclosure provides infectious recombinant adeno-associated virus (rAAV) virions that comprise a variant capsid protein and heterologous nucleic acid. further the (AAV) proteins (and/or acid encoding AAV proteins), which confer to an rAAV virion increased resistance human neutralizing antibodies. host cells comprising and/or subject protein. methods of delivering target cell where is contacted with virion. gene product individual, generally involving administering effective amount individual in need thereof.